Clinical Trials Directory

Trials / Sponsors / Contineum Therapeutics

Contineum Therapeutics

Industry · 8 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingStudy to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fib
Idiopathic Pulmonary Fibrosis
Phase 22026-01-08
CompletedStudy of PIPE-791 for Subjects With Chronic Osteoarthritis Pain or Chronic Low Back Pain
Chronic Osteoarthritis Pain, Chronic Low Back Pain
Phase 12025-02-04
CompletedPET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF
Idiopathic Pulmonary Fibrosis (IPF), Idiopathic Pulmonary Fibrosis, Multiple Sclerosis
Phase 12024-12-09
CompletedStudy to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple Sclerosis
Relapsing Remitting Multiple Sclerosis
Phase 22023-11-06
CompletedStudy Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of PIPE-791 and Food Effect i
Multiple Sclerosis
Phase 12023-06-26
CompletedPET Study to Determine the Relationship Between Plasma Concentrations and Muscarinic Type 1 Receptor (M1AChR)
Multiple Sclerosis
Phase 12021-09-01
CompletedPhase I Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of of PIPE-307 and Fo
Multiple Sclerosis
Phase 12021-02-26
CompletedPhase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing
Sensorineural Hearing Loss
Phase 1 / Phase 22020-10-15